Investigation of critical factors for the resolution of SR695, a key impurity, from efavirenz in the reversed-phase assay of efavirenz dosage forms.
about
Trace Level Quantification of the (-)2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluoro-3-butyn-2-ol Genotoxic Impurity in Efavirenz Drug Substance and Drug Product Using LC-MS/MS.A Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Tenofovir, Emtricitabine, and a Efavirenz and Statistical Approach to Determine the Effect of Variables
P2860
Investigation of critical factors for the resolution of SR695, a key impurity, from efavirenz in the reversed-phase assay of efavirenz dosage forms.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Investigation of critical fact ...... say of efavirenz dosage forms.
@en
Investigation of critical fact ...... say of efavirenz dosage forms.
@nl
type
label
Investigation of critical fact ...... say of efavirenz dosage forms.
@en
Investigation of critical fact ...... say of efavirenz dosage forms.
@nl
prefLabel
Investigation of critical fact ...... say of efavirenz dosage forms.
@en
Investigation of critical fact ...... say of efavirenz dosage forms.
@nl
P2093
P1476
Investigation of critical fact ...... say of efavirenz dosage forms.
@en
P2093
Eda Ross Montgomery
Jim Segretario
Lisa A Junnier
Paul K Hovsepian
Robert P Weissburg
Stacy Cook
P356
10.1016/S0731-7085(01)00638-0
P577
2002-04-01T00:00:00Z